Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?
Kurz S, Wen P. Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma? Current Treatment Options In Neurology 2018, 20: 14. PMID: 29666934, DOI: 10.1007/s11940-018-0499-0.Peer-Reviewed Original ResearchImmunotherapeutic strategiesSafety of CAR-T cell therapyCAR-T cell therapyT cells in vivoChallenges of immunotherapyCAR-T cellsT-cell therapySuccess of immunotherapyHigh-grade gliomasStudy evaluated treatmentIncreased polyclonalityDC vaccinesDiagnosed glioblastomaImmunotherapy researchRecurrent glioblastomaT cellsImmunotherapyEffective therapyClinical evidenceClinical studiesClinical trialsGlioblastoma microenvironmentGlioblastomaPatientsTherapy